Skip to Main Content
Contribute Try STAT+ Today

WASHINGTON — House progressives on Wednesday called for executives from six drug companies to appear on Capitol Hill next week to justify what the lawmakers termed unjustifiable price increases — the latest public display of displeasure from the Democratic Party’s left flank regarding House Speaker Nancy Pelosi’s approach to lowering pharmaceutical costs.

The companies include four brand-name drug manufacturers: Merck, Eli Lilly, Gilead, and Pfizer, a spokeswoman said. The progressives also invited executives from two generic manufacturers: Mylan, the manufacturer of EpiPen, and Mallinckrodt, a company accused of paying bribes to boost sales of a treatment for a rare seizure disorder in infants. Mylan is also among the companies implicated in a sweeping price-fixing lawsuit filed by dozens of state attorneys general.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.